Analgesic Comparison of Transversus Fascial Plane and Quadratus Lumborum Blocks in Pediatric Urogenital Procedures
Comparison of Transversus Fascial Plane Block and Anterior Quadratus Lumborum Block for Lower Urogenital Surgery in Pediatric Patients.
1 other identifier
interventional
68
1 country
1
Brief Summary
This study aims to compare the analgesic effectiveness of the preoperatively administered Anterior Quadratus Lumborum Block (Anterior QLB) and the Transversalis Fascia Plane Block (TFP block) in children undergoing lower abdominal urogenital surgery. The study will include children aged 6 months to 12 years, with randomization performed using the sealed opaque envelope method, and outcome assessment conducted in a double-blinded manner. All patients will receive a standardized anesthesia protocol, and the regional blocks will be performed under ultrasound (US)-guided techniques. Perioperative evaluations will include pain levels, hemodynamic responses, additional analgesic requirements, block performance time, technical success rate, and family satisfaction. Postoperative pain will be monitored using the Face, Legs, Activity, Cry, Consolability (FLACC) scale, and analgesics will be administered when necessary. By comparing these two commonly used regional anesthesia techniques, this study aims to contribute to improved perioperative pain management strategies in the pediatric population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 1, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2026
CompletedSeptember 30, 2026
September 1, 2026
3 months
November 20, 2025
September 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
FLACC scores, Total Analgesic Consumption
the primary outcomes were postoperative FLACC scores at predefined time points and perioperative analgesic consumption, including intraoperative rescue remifentanil and postoperative paracetamol and tramadol during the first 24 hours after surgery.
intraoperatif periods and First 24 hours postoperatively
Secondary Outcomes (3)
time to first mobilization, FLACC scores at during to mobilization
0-24 hours postoperatively
Time to First Rescue Analgesia, FLACC scores
0-24 hours postoperatively
Parent/Patient Satisfaction
24th postoperative hours
Study Arms (2)
Anterior QLB - Preoperative ultrasound-guided anterior quadratus lumborum block
EXPERIMENTALPreoperative ultrasound-guided anterior quadratus lumborum block administered according to standardized anesthesia protocol.
TFP Block - Preoperative ultrasound-guided transversalis fascia plane block
EXPERIMENTALPreoperative ultrasound-guided transversalis fascia plane block administered according to standardized anesthesia protocol.
Interventions
Participants in this group will receive a preoperative ultrasound-guided transversalis fascia plane block. The block will be performed supine under sterile conditions using an in-plane technique with a linear ultrasound probe. The dose of 0.4 ml/kg of 0.25% bupivacaine will be administered according to age and weight. Standardized anesthesia protocols will be applied for all patients. Postoperative pain will be assessed using FLACC scores, and additional analgesics will be administered if required.
Participants in this group will receive a preoperative ultrasound-guided anterior quadratus lumborum block. The block will be performed under sterile conditions using an in-plane technique with a linear ultrasound probe. The dose of 0.4 ml/kg of 0.25% bupivacaine will be administered according to age and weight. Standardized anesthesia protocols will be applied for all patients. Postoperative pain will be assessed using FLACC scores, and additional analgesics will be administered if required.
Eligibility Criteria
You may qualify if:
- Age 6 months to 12 years
- Scheduled for lower abdominal urogenital surgery (e.g., inguinal hernia repair, undescended testis surgery)
- ASA physical status I-III
- Parental/guardian informed consent obtained
You may not qualify if:
- Allergy to local anesthetics
- Infection at the injection site
- Coagulopathy or other contraindications to regional anesthesia
- Laparoscopic orchiopexy scheduled
- ASA physical status IV
- Inability to obtain consent from parent/guardian
- Expected need for postoperative intensive care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
Bakırköy, Istanbul, 34153, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pinar Kendigelen
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
- STUDY CHAIR
Munevver Kayhan
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
- STUDY CHAIR
Ayse Cigdem Tutuncu, Professor Doctor
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants: Blinded PACU nurses: Blinded Ward nurses: Blinded Postoperative follow-up anesthesiologist: Blinded Data analyst: Blinded Block-performing anesthesiologist: Not blinded Randomization investigator: Independent from recruitment, block performance, and assessment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 1, 2025
Study Start
December 1, 2025
Primary Completion
March 5, 2026
Study Completion
March 5, 2026
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share